The virtual NRM 2021 meeting will be held from December 14 – 16, 2021.
Since 1997, the NRM convenes experts in the field of neuroreceptors and serves as a platform to discuss the latest breakthroughs in quantifying neuroreceptors in the human brain using Positron Emission Tomography (PET).
A wide range of methodological advances are traditionally discussed, including novel brain molecular imaging agents, pharmacokinetic analysis, radio metabolites and analytical methods are traditionally discussed in this meeting. Furthermore, the NRM includes sections devoted to neuroreceptor abnormalities in neuropsychiatric and neurological conditions with particular attention to quantification of protein aggregates in neurodegenerative conditions.
We are pleased that two AMYPAD abstracts have been accepted for an oral presentation:
For more information about the conference, please visit: https://www.nrm2021.org/